Sarah Cannon Research Institute (SCRI)

Research facility


Location: Nashville, TN, United States (USA) (US) US

ISNI: 0000000404595478

ROR: https://ror.org/014t21j89

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor plus (HR plus ) metastatic breast cancer (MBC) who have previously received a taxane (2021) O'Shaughnessy J, Schwartzberg L, Piccart M, Rugo HS, Yardley DA, Cortes J, Untch M, et al. Conference contribution International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders (2019) Hillengass J, Usmani S, Rajkumar SV, Durie BG, Mateos MV, Lonial S, Joao C, et al. Journal article, Review article
‹ 1 2 ›